NexGelRx,

Langhorne, United States

NexGelRx is a spin-off company developing prescription drug delivery solutions using proprietary hydrogel technology.

$1.3M raised

Dec 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NexGelRx, raised?

NexGelRx, has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are NexGelRx,'s investors?

NexGelRx,'s investors include Ariel Imas, Eric Gruntfest.

Where is NexGelRx, headquartered?

NexGelRx, is headquartered in Langhorne, United States.

What does NexGelRx, do?

NexGelRx is a spin-off company developing prescription drug delivery solutions using proprietary hydrogel technology.

What stage is NexGelRx, at?

NexGelRx, is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 16, 2025.

MLA

"NexGelRx, — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/nexgelrx. Accessed July 5, 2026.

APA

VCBacked. (2025). NexGelRx, — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/nexgelrx

Wikipedia (cite web)

{{cite web |title=NexGelRx, — Funding & Investors |url=https://www.vcbacked.co/company/nexgelrx |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 16, 2025.